Logistic regression model for predicting risk factors and contribution of cerebral microbleeds using renal function indicators
- PMID: 39364422
- PMCID: PMC11447291
- DOI: 10.3389/fneur.2024.1428625
Logistic regression model for predicting risk factors and contribution of cerebral microbleeds using renal function indicators
Abstract
Background: The brain and kidneys share similar low-resistance microvascular structures, receiving blood at consistently high flow rates and thus, are vulnerable to blood pressure fluctuations. This study investigates the causative factors of cerebral microbleeds (CMBs), aiming to quantify the contribution of each risk factor by constructing a multivariate model via stepwise regression.
Methods: A total of 164 hospitalized patients were enrolled from January 2022 to March 2023 in this study, employing magnetic susceptibility-weighted imaging (SWI) to assess the presence of CMBs. The presence of CMBs in patients was determined by SWI, and history, renal function related to CMBs were analyzed.
Results: Out of 164 participants in the safety analysis, 36 (21.96%) exhibited CMBs and 128 (78.04%) did not exhibit CMBs, and the median age of the patients was 66 years (range: 49-86 years). Multivariate logistic regression identified hypertension (OR = 13.95%, 95% CI: 4.52, 50.07%), blood urea nitrogen (BUN) (OR = 1.57, 95% CI: 1.06-2.40), cystatin C (CyC) (OR = 4.90, 95% CI: 1.20-22.16), and urinary β-2 microglobulin, (OR = 2.11, 95% CI: 1.45-3.49) as significant risk factors for CMBs. The marginal R-square ( ) was 0.25. Among all determinants, hypertension (47.81%) had the highest weight, followed by UN (11.42%). Quasi-curves plotted using the bootstrap method (999 times) showed good agreement between the predictive model and actual observations.
Conclusion: Hypertension, BUN, urinary β-2 microglobulin, CyC were risk factors for CMBs morbidity, and controlling the above indicators within a reasonable range will help to reduce the incidence of CMBs.
Keywords: cerebral microbleeds; contribution; hypertension; renal function indicators; risk factors.
Copyright © 2024 Liu, Pan, Li, Huang, Zhang and Xiong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
Risk Factor Analysis in Patients Exhibiting Cerebral Microbleeds and the Correlation with Cognitive Impairment.Gerontol Geriatr Med. 2024 Sep 4;10:23337214241278497. doi: 10.1177/23337214241278497. eCollection 2024 Jan-Dec. Gerontol Geriatr Med. 2024. PMID: 39238650 Free PMC article.
-
Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients.Am J Hypertens. 2015 Jun;28(6):739-45. doi: 10.1093/ajh/hpu229. Epub 2014 Dec 12. Am J Hypertens. 2015. PMID: 25498995
-
Analysis of Risk Factors for Cerebral Microbleeds and the Relationship between Cerebral Microbleeds and Cognitive Impairment.Brain Sci. 2022 Oct 26;12(11):1445. doi: 10.3390/brainsci12111445. Brain Sci. 2022. PMID: 36358371 Free PMC article.
-
Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds.BMC Neurol. 2014 Jun 12;14:127. doi: 10.1186/1471-2377-14-127. BMC Neurol. 2014. PMID: 24925313 Free PMC article.
-
Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis.Europace. 2022 Oct 13;24(9):1395-1403. doi: 10.1093/europace/euac028. Europace. 2022. PMID: 35244694
Cited by
-
Comprehensive predictive model for cerebral microbleeds: integrating clinical and biochemical markers.Front Neurosci. 2024 Dec 13;18:1429088. doi: 10.3389/fnins.2024.1429088. eCollection 2024. Front Neurosci. 2024. PMID: 39734492 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials